Buckley Wealth Management, LLC Biogen Inc. Transaction History

Buckley Wealth Management, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 27, 2021	SELL	$259.0 - $414.71 $303,030 - $485,210	-1,170 Closed	0 $0
Q1 2021 Apr 30, 2021	SELL	$242.95 - $284.63 $89,162 - $104,459	-367 Reduced 23.88%	1,170 $327,000
Q4 2020 Jan 20, 2021	SELL	$236.26 - $355.63 $23,862 - $35,918	-101 Reduced 6.17%	1,537 $376,000
Q3 2020 Oct 19, 2020	BUY	$264.77 - $305.71 $26,477 - $30,570	100 Added 6.5%	1,638 $465,000
Q3 2019 Oct 11, 2019	BUY	$217.44 - $243.88 $6,305 - $7,072	29 Added 1.92%	1,538 $358,000
Q2 2019 Jul 19, 2019	BUY	$219.29 - $241.72 $119,074 - $131,253	543 Added 56.21%	1,509 $353,000
Q4 2018 Feb 01, 2019	SELL	$278.5 - $352.75 $3,620 - $4,585	-13 Reduced 1.33%	966 $291,000
Q3 2018 Oct 25, 2018	BUY	$293.51 - $383.83 $587 - $767	2 Added 0.2%	979 $346,000
Q2 2018 Jul 31, 2018	SELL	$257.52 - $306.91 $6,438 - $7,672	-25 Reduced 2.5%	977 $284,000
Q1 2018 May 08, 2018	SELL	$260.13 - $367.91 $13,526 - $19,131	-52 Reduced 4.93%	1,002 $274,000
Q4 2017 Feb 07, 2018	BUY	$307.64 - $344.58 $324,252 - $363,187	1,054	1,054 $336,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Buckley Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Buckley Wealth Management, LLC with notifications on news.